GLAD Law: How Members of the Local LGBTQ+ Community Can Prepare for Trump Administration

Local activists have highlighted the anti-trans rhetoric that was a significant aspect of President-elect Donald Trump’s campaign. With less than three weeks until he begins his second term, what should members of the local LGBTQ community know in order to prepare?

A recent Rhode Island LGBTQ pride parade in Providence.
A recent Rhode Island LGBTQ pride parade in Providence.
File photo/The Public’s Radio
Share
A recent Rhode Island LGBTQ pride parade in Providence.
A recent Rhode Island LGBTQ pride parade in Providence.
File photo/The Public’s Radio
GLAD Law: How Members of the Local LGBTQ+ Community Can Prepare for Trump Administration
Copy

As Donald Trump prepares for his second term in the White House, Sarah Austin, staff attorney with GLAD Law, spoke with Luis Hernandez about possible threats to LGBTQ rights, and what members of the local LGBTQ community can do to prepare.

Interview highlights:

On possible threats to LGBTQ rights:

Sarah Austin:
I think it’s very clear that the incoming administration is going to target LGBTQ+ people and our rights, especially when it comes to transgender health care, transgender military service, and non-discrimination protections for LGBTQ students.

We do anticipate that the incoming administration is going to try to restrict access to transgender health care and try to restrict insurance coverage of that health care. The way that that’s likely to happen is through conditions on federal funding to major health care providers and also to states.

This interview was conducted by The Public’s Radio. You can read the entire story here.

Health officials say an East Providence mosquito tested positive for West Nile Virus, urging residents to use repellent and eliminate standing water as mosquito season ramps up.
Rhode Island Attorney General Peter Neronha says new funding plans aim to resolve a multimillion-dollar gap and secure the future of the long-struggling CharterCARE hospitals
The Woonsocket-based health care giant reported $98.9 billion in revenue, boosted by higher prescription volume and a 39% jump in health insurance income, sending shares up 8% in premarket trading